TY - JOUR
T1 - La chirurgia "function sparing" in urologia oncologica
T2 - tumori germinali del testicolo (TGT)
AU - Catanzaro, Mario
AU - Piva, Luigi
AU - Torelli, Tullio
AU - Biasoni, Davide
AU - Stagni, Silvia
AU - Milani, Angelo
AU - Necchi, Andrea
AU - Giannatempo, Patrizia
AU - Nicolai, A.
AU - Salvioni, Roberto
PY - 2012
Y1 - 2012
N2 - Surgery in germ cell tumors of the testis (TGT) may result in andrological disorders, both after orchiectomy and after retroperitoneal lymphadenectomy (RPLND). Bilateral orchiectomy suppresses both testicular functions: exocrine and endocrine. In selected cases with bilateral TGT (metachronous/synchronous), or in the case of TGT in monorchid patients, partial orchiectomy (enucleation of the tumor) can preserve both functions with a low risk of relapse in residual testicular parenchyma, in the absence of intraepithelial neoplasia (TIN). In cases of TIN and normal testosterone levels (80%), the fertility is maintained in 50% of patients. In these cases the use of radiotherapy on the residual testicular parenchyma can prevent the future development of invasive cancer, though compromising the hormonal function. The RPLND (open or laparoscopic) can produce major side effects, such as retrograde ejaculation. Knowledge of the adrenergic fiber retroperitoneal neuroanatomy enables to implement a "nerve sparing" surgery with an almost total reduction of this serious side effect, but that option is only available in few centers of excellence. Semen cryopreservation has become a common practice performed before any treatment that might impact on the andrological function of patients.
AB - Surgery in germ cell tumors of the testis (TGT) may result in andrological disorders, both after orchiectomy and after retroperitoneal lymphadenectomy (RPLND). Bilateral orchiectomy suppresses both testicular functions: exocrine and endocrine. In selected cases with bilateral TGT (metachronous/synchronous), or in the case of TGT in monorchid patients, partial orchiectomy (enucleation of the tumor) can preserve both functions with a low risk of relapse in residual testicular parenchyma, in the absence of intraepithelial neoplasia (TIN). In cases of TIN and normal testosterone levels (80%), the fertility is maintained in 50% of patients. In these cases the use of radiotherapy on the residual testicular parenchyma can prevent the future development of invasive cancer, though compromising the hormonal function. The RPLND (open or laparoscopic) can produce major side effects, such as retrograde ejaculation. Knowledge of the adrenergic fiber retroperitoneal neuroanatomy enables to implement a "nerve sparing" surgery with an almost total reduction of this serious side effect, but that option is only available in few centers of excellence. Semen cryopreservation has become a common practice performed before any treatment that might impact on the andrological function of patients.
UR - http://www.scopus.com/inward/record.url?scp=84922415005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922415005&partnerID=8YFLogxK
U2 - 10.5301/RU.2012.9736
DO - 10.5301/RU.2012.9736
M3 - Articolo
C2 - 23371266
AN - SCOPUS:84922415005
VL - 79
SP - 15
EP - 19
JO - Urologia
JF - Urologia
SN - 0391-5603
ER -